ResMed Inc.RMDNYSE
LOADING
|||
RMDR&D Expense Growth Recovery in Progress
Trending higher, below historical average, modest growth trend.
Left:
|||
Year-over-year research & development expense growth
Latest
7.73%
↓ 32% below average
Average (9y)
11.29%
Historical baseline
Range
High:21.76%
Low:3.30%
CAGR
+9.9%
Consistent expansion
| Period | Value |
|---|---|
| 2025 | 7.73% |
| 2024 | 6.91% |
| 2023 | 13.43% |
| 2022 | 12.56% |
| 2021 | 11.56% |
| 2020 | 11.79% |
| 2019 | 16.44% |
| 2018 | 7.39% |
| 2017 | 21.76% |
| 2016 | 3.30% |